pubmed-article:6391464 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0234421 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0035096 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0001563 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0005823 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0205341 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0232105 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
pubmed-article:6391464 | lifeskim:mentions | umls-concept:C0072178 | lld:lifeskim |
pubmed-article:6391464 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:6391464 | pubmed:dateCreated | 1985-1-22 | lld:pubmed |
pubmed-article:6391464 | pubmed:abstractText | The magnitude and the persistence of blood pressure reduction by propyldazine (PDZ) was investigated following treatment over a period of 4 days. The experiments were performed on 6 normotensive dogs trained to submit to puncture of the femoral artery and to stand quietly in a special frame over the experimental period of 7 to 8 hours. The first dose effect of orally administered PDZ (0.06, 0.29 and 1.42 mg/kg) on heart rate, arterial blood pressure and plasma renin activity (PRA) was compared with the effect of the substance after treatment at the same respective dosage twice daily over 4 days. The compound caused a dose-dependent decrease in blood pressure accompanied by dose-dependent increases in heart rate and PRA. With 0.06 mg/kg and 0.29 mg/kg PDZ a sustained effect on arterial blood pressure was observed, whereas with 1.42 mg/kg PDZ tolerance occurred after treatment over the 4-day period. A comparison with the effects observed previously with 1.42 and 7.1 mg/kg dihydralazine (DHZ) under identical conditions showed similar results with respect to dose-dependence of blood pressure and counterregulation (1). It is considered that with a low-dose regimen there would be no decrease in activity of PDZ, the long-term hypotensive efficacy of the drug thereby being guaranteed. | lld:pubmed |
pubmed-article:6391464 | pubmed:language | eng | lld:pubmed |
pubmed-article:6391464 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6391464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6391464 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6391464 | pubmed:issn | 0300-8428 | lld:pubmed |
pubmed-article:6391464 | pubmed:author | pubmed-author:KrauppOO | lld:pubmed |
pubmed-article:6391464 | pubmed:author | pubmed-author:RabergerGG | lld:pubmed |
pubmed-article:6391464 | pubmed:author | pubmed-author:BeckAA | lld:pubmed |
pubmed-article:6391464 | pubmed:author | pubmed-author:SeitelbergerR... | lld:pubmed |
pubmed-article:6391464 | pubmed:author | pubmed-author:BacherSS | lld:pubmed |
pubmed-article:6391464 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6391464 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:6391464 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6391464 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6391464 | pubmed:pagination | 588-97 | lld:pubmed |
pubmed-article:6391464 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:meshHeading | pubmed-meshheading:6391464-... | lld:pubmed |
pubmed-article:6391464 | pubmed:articleTitle | Altered blood pressure response to propyldazine after repeated oral administration in conscious normotensive dogs: role of the renin-angiotensin system. | lld:pubmed |
pubmed-article:6391464 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6391464 | pubmed:publicationType | Comparative Study | lld:pubmed |